Published March 29, 2022 Ned Pagliarulo Lead Editor Jeenah Moon via Getty Images Dive Brief: An experimental inflammatory disease drug acquired by Pfizer earlier this year met all of its goals in the second of two late-stage trials testing its potential in treating ulcerative colitis, a chronic bowel disease that affects millions of people in the U.S....
